(1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol

C36H47N4O2- — CID 163122573

IUPAC(1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol
SMILES[O-]N1CCc2c([nH]c3ccccc23)C1C1=C[C@@]2(O)CC/C=C\CCCCN3CC[C@@H]1[C@]1(CC4/C=C\CCCCN4[C@H]12)C3
InChIInChI=1S/C36H47N4O2/c41-36-18-10-4-1-2-5-11-19-38-21-17-30(35(25-38)23-26-13-7-3-6-12-20-39(26)34(35)36)29(24-36)33-32-28(16-22-40(33)42)27-14-8-9-15-31(27)37-32/h1,4,7-9,13-15,24,26,30,33-34,37,41H,2-3,5-6,10-12,16-23,25H2/q-1/b4-1-,13-7-/t26?,30-,33?,34+,35-,36-/m0/s1
InChIKeyUFRYZKFUQFDMBN-FPUPDBDDSA-N
MW567.80 g/mol
LogP6.25
Rot. Bonds1

About (1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol

(1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol (PubChem CID 163122573) has the molecular formula C36H47N4O2- and a molecular weight of 567.80 g/mol. Its IUPAC name is (1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol.

Molecular Properties

Compound Name(1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol
PubChem CID163122573
Molecular FormulaC36H47N4O2-
Molecular Weight567.80 g/mol
Exact Mass567.37
IUPAC Name(1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol
SMILES[O-]N1CCc2c([nH]c3ccccc23)C1C1=C[C@@]2(O)CC/C=C\CCCCN3CC[C@@H]1[C@]1(CC4/C=C\CCCCN4[C@H]12)C3
InChIInChI=1S/C36H47N4O2/c41-36-18-10-4-1-2-5-11-19-38-21-17-30(35(25-38)23-26-13-7-3-6-12-20-39(26)34(35)36)29(24-36)33-32-28(16-22-40(33)42)27-14-8-9-15-31(27)37-32/h1,4,7-9,13-15,24,26,30,33-34,37,41H,2-3,5-6,10-12,16-23,25H2/q-1/b4-1-,13-7-/t26?,30-,33?,34+,35-,36-/m0/s1
InChIKeyUFRYZKFUQFDMBN-FPUPDBDDSA-N
XLogP6.25
TPSA68.80 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds1
Heavy Atoms42
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500567.80
LogP ≤ 56.25
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol?
The IUPAC name of (1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol (CID 163122573) is (1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol.
What is the SMILES notation for (1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol?
The canonical SMILES for (1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol is [O-]N1CCc2c([nH]c3ccccc23)C1C1=C[C@@]2(O)CC/C=C\CCCCN3CC[C@@H]1[C@]1(CC4/C=C\CCCCN4[C@H]12)C3.
What is the InChIKey of (1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol?
The InChIKey is UFRYZKFUQFDMBN-FPUPDBDDSA-N. The full InChI is InChI=1S/C36H47N4O2/c41-36-18-10-4-1-2-5-11-19-38-21-17-30(35(25-38)23-26-13-7-3-6-12-20-39(26)34(35)36)29(24-36)33-32-28(16-22-40(33)42)27-14-8-9-15-31(27)37-32/h1,4,7-9,13-15,24,26,30,33-34,37,41H,2-3,5-6,10-12,16-23,25H2/q-1/b4-1-,13-7-/t26?,30-,33?,34+,35-,36-/m0/s1.
What are the key properties of (1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol?
(1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol has a molecular weight of 567.80 g/mol, XLogP of 6.25, 1 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,2R,5Z,12R,13S,16Z)-25-(2-oxido-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol is sourced from PubChem (CID 163122573), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).